The 05 in vitro III (microbiology) department provides a comprehensive range of services dedicated to assessing the biological safety and antimicrobial performance of biomedical materials, alongside the specialized culture and utilization of microbial resources. We offer precise ex situ, in situ, and ex vivo assays to evaluate efficacy, assess biofilm inhibition, and ensure material functionality against pathogenic organisms in various environments.
| Service ID | Service Title | Description |
|---|---|---|
| 05.01 | Specialized Microbial Culture & Cultivation | Cultivation of various microorganisms, including microalgae and fungi, tailored for specific applications in biomedical research and product development. |
| 05.02 | Microbial Product Extraction & Purification | Purification and extraction of valuable microbial byproducts, such as exosomes, from cultivated microalgae and fungi for use in drug delivery systems and tissue engineering. |
| 05.03 | Quantitative Antimicrobial Efficacy Testing | Precise determination of the antimicrobial potential of biomaterials using standard quantitative assays, including Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Concentration (MBC) tests. |
| 05.04 | Qualitative Antimicrobial Screening | Rapid assessment of antimicrobial activity and susceptibility using methods such as the Disc Diffusion Test and other zone of inhibition analyses. |
| 05.05 | Microbial Growth and Colonization Assays | Quantitative measurement of bacterial growth and adherence using techniques like Optical Density (OD) measurements and Spread Tests to assess colonization rates. |
| 05.06 | Biofilm Formation and Inhibition Studies | Comprehensive assessment of a material’s capacity to inhibit or promote biofilm formation and adherence using established techniques, including Crystal Violet Staining. |
| 05.07 | Advanced Viability & Population Analysis | Detailed evaluation of microbial cell viability, membrane integrity, and population dynamics using sophisticated fluorescent stains (e.g., SYTO9 and PI live/dead assays) and Flow Cytometry. |
| 05.08 | Contextual Efficacy Evaluation (Ex Situ, In Situ, Ex Vivo) | Specialized microbiological assessments conducted under various experimental conditions: ex situ (controlled), in situ (native-like environment), and ex vivo (on freshly isolated tissues). |
